TGTX provided first-quarter 2024 financial results, with BRIUMVI U.S. net revenue of $50.5 million, a 25% increase quarter over quarter contributing to total revenue of $63.5 million$TG Therapeutics(TGTX)$
| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
TGTX provided first-quarter 2024 financial results, with BRIUMVI U.S. net revenue of $50.5 million, a 25% increase quarter over quarter contributing to total revenue of $63.5 million$TG Therapeutics(TGTX)$